AVITA Medical, Inc.RCELNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank49
3Y CAGR-6.7%
5Y CAGR+30.7%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-6.7%/yr
vs -65.8%/yr prior
5Y CAGR
+30.7%/yr
Recent deceleration
Acceleration
+59.1pp
Accelerating
Percentile
P49
Within normal range
vs 5Y Ago
3.8x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 3.25% |
| Q3 2025 | -7.36% |
| Q2 2025 | -0.52% |
| Q1 2025 | 0.59% |
| Q4 2024 | -5.83% |
| Q3 2024 | 28.63% |
| Q2 2024 | 36.84% |
| Q1 2024 | -21.78% |
| Q4 2023 | 4.03% |
| Q3 2023 | 16.10% |
| Q2 2023 | 11.40% |
| Q1 2023 | 11.58% |
| Q4 2022 | 3.99% |
| Q3 2022 | 9.08% |
| Q2 2022 | 10.56% |
| Q1 2022 | 8.69% |
| Q4 2021 | -1.20% |
| Q3 2021 | -31.87% |
| Q2 2021 | 17.56% |
| Q1 2021 | 71.76% |
| Q4 2020 | 0.85% |
| Q3 2020 | 30.51% |
| Q2 2020 | 0.00% |
| Q1 2020 | 18.96% |
| Q4 2019 | -32.32% |
| Q3 2019 | 130.02% |
| Q2 2019 | 0.00% |
| Q1 2019 | 227.82% |
| Q4 2018 | -2.54% |
| Q3 2018 | 151.18% |
| Q2 2018 | 14.90% |
| Q1 2018 | -4.25% |
| Q4 2017 | -0.50% |
| Q3 2017 | -5.88% |
| Q2 2017 | 0.60% |
| Q1 2017 | 33.71% |
| Q4 2016 | -5.73% |
| Q3 2016 | 24.83% |
| Q2 2016 | -3.07% |
| Q1 2016 | -20.84% |